Jacksonville, Fla.-based health insurer Florida Blue has selected Amazon Pharmacy as its sole home delivery provider for its commercially insured members beginning Jan. 1, 2023.
Florida Blue's two million plus members in its individual and employer group plans, including Florida Blue-related health plan Truli for Health, will receive free home delivery on common prescription medications through...
Digital diagnostics company ixlayer announced it will produce CVS Health's branded at-home sample collection kits.
Ixlayer's kits can test for Lyme disease, Vitamin D levels, thyroid function and sexually transmitted infections. Users are also provided education and information about what the results mean.
Consumers can now purchase the CVS Health-branded tests online or pick up a test in-store...
New Mexico-based telehealth and technology services company Electronic Caregiver announced the close of its latest funding round that raised $30 million, plus a warrant exercise, for a total of $42.5 million.
The new funds will help expand the company's revenue and customer base, leading to a planned IPO within 24 months.
The company offers remote patient monitoring and chronic care management...
SubjectWell, a patient recruitment platform for clinical trials, announced it raised $35 million in a Series B funding round led by Asset Management Ventures.
Other participants in the round include Bertelsmann and existing investors Healthy Ventures, Windham Venture Partners and Geekdom Fund.
According to Crunchbase, the Texas-based company has raised $46.8 million over seven funding rounds....
Unified Women's Healthcare, a health-management company focused solely on women, announced its acquisition of Gennev, a digital menopause care-delivery platform. The financial terms of the deal were not disclosed.
Seattle-based Gennev, previously known as Genneve, provides menopause patients personalized treatment through its network of OB-GYNs, health coaches and registered dietitians.
The...
The FDA on Thursday released draft guidance for its Breakthrough Devices Program aimed at reducing health disparities.
The draft proposes updates that would clarify how the program would apply to medical devices that could benefit groups affected by health inequities, including disparities based on race, sex, ethnicity and access to care. The agency will also assess if the developers have...
Cambridge-based Sinaptica Therapeutics, a company providing electromagnetic treatment for patients with neurodegenerative diseases, announced its receipt of FDA Breakthrough Device Designation for its non-invasive SinaptiStim - AD System, designed to treat cognitive and functional decline in Alzheimer's patients.
SinaptiStim uses neurostimulation and brain wave monitoring technologies with an AI...
A cross-sectional study found increased EHR use among primary care physicians was associated with improvement in some quality measures, like diabetes and hypertension control and adherence to breast cancer screening.
The study, published in JAMA Network Open and conducted through Brigham and Women's Hospital and Massachusetts General Hospital in 2021, examined 291 primary care physicians'...
British multinational pharmaceutical and biotech company GSK announced a three-year agreement with a $70 million initial payment to expand its access to Tempus' AI-powered data library, including its de-identified patient data.
GSK says the collaboration will allow it to leverage the U.S.-based company's library to accelerate drug discovery in oncology, improve its clinical trial design,...
Signify Health, which offers technology and analytics services to support value-based care arrangements, is expanding its in-home diagnostic and preventative services offering for Medicaid and Medicare Advantage plan members.
The program supports Signify's In-Home Health Evaluation service, assisting with the detection, diagnosis and management of some of the leading causes of morbidity and...